FDA OKs Phase 1 study of two-component immunotherapy
The FDA approved the launch of a clinical trial to evaluate the safety and effectiveness of its two-component immunotherapy for lupus.| Lupus News Today
The FDA approved the launch of a clinical trial to evaluate the safety and effectiveness of its two-component immunotherapy for lupus.| Lupus News Today
Fibroblast cell-based therapies will be more accessible to patients, more effective, and less expensive than stem cells.| FibroBiologics
Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology &...| Lupus News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
The additional heat and light of spring can be dangerous with lupus. Here's how columnist Marisa Zeppieri navigates the change of seasons.| Lupus News Today
